Acadia Pharmaceuticals Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+31.7% +$376M
$1.56B
Current Assets↑+13.2% +$124M
$1.06B
Cash & Equivalents↓-44.4% -$142M
$178M
ST Investments
—
Receivables↑+23.0% +$23M
$121M
Inventory↑+21.5% +$20M
$111M
Net PPE↑+78.2% +$3M
$8M
Intangibles↓-9.1% -$11M
$109M
Total Liabilities↓-26.0% -$118M
$337M
Current Liabilities↓-29.8% -$118M
$277M
Account Payables↓-32.7% -$5M
$11M
Stockholders Equity↑+67.5% +$495M
$1.23B
Retained Earnings↑+17.7% +$391M
$-1.81B
Operating Lease ROU Asset↑+1.7% +$783K
$47M
Operating Lease Liability↑+0.4% +$192K
$52M
Gross PP&E↑+17.8% +$3M
$17M
Accumulated Depreciation↓-7.2% -$733K
$9M
Inventory Raw Materials↑+18.7% +$13M
$83M
Inventory WIP↑+77.3% +$1M
$3M
Inventory Finished Goods↑+26.8% +$5M
$26M